Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transcription factor RFX4 is a protein encoded by the RFX4 gene, belonging to the regulatory factor X gene family and characterized by a winged-helix DNA-binding domain[1][3][2][6]. RFX4 is mainly involved in the transcriptional regulation of genes important for early brain and neural tube development and may influence neural tube ciliogenesis and Shh signaling. Several alternative splice isoforms exist, with tissue-specific expression in the central nervous system and testis. RFX4 interacts with other family members (RFX2, RFX3) and can act as a repressor or activator at target promoters, depending on cellular context. Dysfunction or mutation of RFX4 is implicated in rare developmental disorders such as Dandy-Walker syndrome and certain brain tumors like melanotic medulloblastoma[1][3][4][6].
Not applicable (no drugs currently known to target RFX4 directly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transcription factor RFX4 (RFX4).